EnteroMix
EnteroMix (Russian: ЭнтероМикс) is an experimental cancer immunotherapy under development in Russia. According to its developers, EnteroMix is a mixture of four oncolytic viruses—replication-competent human enteroviruses including Coxsackievirus A21, Echovirus 7, Enterovirus B75, and a modified derivative of a Sabin poliovirus vaccine strain—and is administered intravenously.